Market Tracker

05/26 3:23am ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

32.01
Delayed Data
As of May 22
 -0.25 / -0.77%
Today’s Change
28.26
Today|||52-Week Range
45.45
-21.68%
Year-to-Date

Today’s Trading

Previous close32.26
Today’s open32.08
Day’s range31.92 - 32.19
Volume476,003
Average volume (3 months)655,514
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-172.63%
Earnings growth (next 5 years)+37.00%
Revenue growth (last year)+19.34%
P/E ratio98.0
Price/Sales4.19
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...+0.10+0.80%
INSMInsmed Inc-0.15-0.66%
RGENRepligen Corp-0.31-0.75%
ZSPHZS Pharma Inc+1.44+2.55%
Data as of 3:59pm ET, 05/22/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts